Related Experiment Video
Updated: Aug 19, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis
1Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Abstract:
Human Kruppel-like factor 2 (KLF2) is a Cys(2)/His(2) zinc-finger-containing transcriptional factor, which is involved in multiple cellular pathways. Utilizing gene expression profiling to identify aberrantly expressed genes in ovarian cancer, we found that KLF2 was significantly and specifically downregulated in ovarian tumors. After reintroducing KLF2 into ovarian cancer cell lines, we observed decreased cell growth and increased sensitivity to DNA damage-induced apoptosis. Analysis of genes that could be potential targets of KLF2 revealed that KLF2 negatively regulated WEE1 expression. WEE1 encodes a tyrosine kinase that regulates the G2/M cell cycle transition. Expression of KLF2 markedly repressed the transcription of WEE1 by directly binding to an SP1/CPBP motif located between -252 bp and the start codon of the WEE1 promoter. Both activation and zinc-finger domains of KLF2 were required for this suppression of Wee1 expression. In addition, we demonstrated that Wee1 expression prevents cancer cells from undergoing apoptosis in response to DNA damage; however, this resistance was abolished by coexpression of KLF2, which inhibits WEE1 transcription. Thus, the level of WEE1 is regulated by KLF2 and enhanced KLF2 expression sensitizes cells to DNA damage-induced apoptosis.
Insights
Human Kruppel-like factor 2 (KLF2) is downregulated in ovarian cancer. Restoring KLF2 inhibits tumor growth and increases sensitivity to DNA damage by suppressing WEE1 expression.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Human Kruppel-like factor 2 (KLF2) is a transcription factor involved in cellular pathways.
- KLF2 is significantly downregulated in ovarian tumors.
- WEE1 kinase regulates the G2/M cell cycle transition.
Purpose of the Study:
- To investigate the role of KLF2 in ovarian cancer.
- To identify KLF2 target genes and elucidate its regulatory mechanisms.
- To explore KLF2's impact on cancer cell sensitivity to DNA damage.
Main Methods:
- Gene expression profiling to identify KLF2 dysregulation in ovarian cancer.
- Reintroduction of KLF2 into ovarian cancer cell lines.
- Analysis of KLF2's transcriptional regulation of WEE1, including promoter binding assays.
- Assessment of KLF2 and WEE1 expression on cell growth, apoptosis, and DNA damage response.
Main Results:
- KLF2 is significantly downregulated in ovarian tumors.
- Reintroducing KLF2 reduced ovarian cancer cell growth and increased apoptosis sensitivity.
- KLF2 directly represses WEE1 transcription by binding to its promoter.
- KLF2-mediated WEE1 suppression enhances apoptosis in response to DNA damage.
Conclusions:
- KLF2 acts as a tumor suppressor in ovarian cancer.
- KLF2 regulates WEE1 expression, impacting cell cycle and DNA damage response.
- Enhanced KLF2 expression sensitizes ovarian cancer cells to DNA damage-induced apoptosis, suggesting therapeutic potential.
More Related Videos
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair

